Acquisitions (Details 1)	12 Months Ended
Jun. 30, 2020 USD ($)
Goodwill, beginning balance	$ 0
Goodwill, ending balance	28,090,407
Cerecor, Inc.
Goodwill, beginning balance	15,387,064
Increase due change in estimated fixed payment obligations	3,766,071
Increase to account for settlement with former product licensor	300,000
Goodwill, ending balance	19,453,135
Innovus Pharmaceuticals
Goodwill, beginning balance	8,374,269
Increase due to settlements related to lawsuit and product royalties	209,178
Increase due to additional bonus accrual	53,825
Goodwill, ending balance	$ 8,637,272

Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(10)(1))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266

Name:	us-gaap_Goodwill
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant